Skip to content
Open access · CC-BY via OpenAlex

Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing

Heba Adel, Aya Mohamed Adel Arafat, Eman Hazem AbdelTawab Khattab, Mustafa Ashraf Khattab, Ahmed Mahmoud Khallaf, Shirihan Mahmoud Anwar Mahgoub

World Journal of Stem Cells · 2026

Abstract

Hematopoietic stem cells (HSCs) occupy the apex of the blood cell hierarchy, and artificial intelligence (AI) is fundamentally reshaping how their biology is decoded from normal self-renewal to malignant transformation and clinical transplantation. Trajectory inference algorithms applied to single-cell multi-omics have resolved continuous HSC differentiation with lineage priming detectable at the single-cell level, while convolutional neural networks trained on chromatin imaging predict HSC biological age and detect epigenetic rejuvenation signatures. In leukemic stem cell (LSC) biology, multi-omics deep learning models map treatment-resistant quiescent LSC subclones, detect minimal residual disease with an area under the curve of 0.97 and predict venetoclax sensitivity in LSC-enriched niches. Deep learning also maps myeloma stem cell niche interactions and spatial heterogeneity in bone marrow biopsies. Virtual screening powered by AI speeds up LSC-targeted drug discovery, and reinforcement learning and digital twin models improve ex vivo HSC manufacturing and industrial-scale production of chimeric antigen receptor-T cells. In transplantation, natural language processing extraction and hybrid models classify risk for graft-vs -host disease into clinically relevant subgroups. Overall, top-performing AI models serve as computational surrogates for stemness biology but challenges in dataset diversity, interpretability and regulatory compliance need to be addressed before being used in a clinical setting.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4252/wjsc.121077
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Adel, H., Arafat, A.M.A., Khattab, E.H.A., Khattab, M.A., Khallaf, A.M., &amp; Mahgoub, S.M.A. (2026). Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.121077
Vancouver
Adel H, Arafat AMA, Khattab EHA, Khattab MA, Khallaf AM, Mahgoub SMA. Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. World Journal of Stem Cells. 2026. doi:10.4252/wjsc.121077.
BibTeX
@article{heba2026Artifi, title = {Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing}, author = {Heba Adel and Aya Mohamed Adel Arafat and Eman Hazem AbdelTawab Khattab and Mustafa Ashraf Khattab and Ahmed Mahmoud Khallaf and Shirihan Mahmoud Anwar Mahgoub}, journal = {World Journal of Stem Cells}, year = {2026}, doi = {10.4252/wjsc.121077}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings